Double dissociated effects of the functional TNF-α -308G/A polymorphism on processes of cognitive control

Neuropsychologia

Volumn 49, Issue 2, 2011, Pages 196-202

  Beste, Christian ^a   Güntürkün, Onur ^a   Baune, Bernhard T ^b   Domschke, Katharina ^c   Falkenstein, Michael ^d   Konrad, Carsten ^c,e  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Basal ganglia; Error processing; Event related potentials (ERPs); Response inhibition; TNF alpha polymorphism

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BASAL GANGLION; COGNITION; CONTROLLED STUDY; EVENT RELATED POTENTIAL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROBIOLOGY; NEUROPHYSIOLOGY; NEUROTRANSMISSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STIMULUS RESPONSE;

ADULT; CHOICE BEHAVIOR; DISSOCIATIVE DISORDERS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTION TIME; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 78650856506     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2010.11.037     Document Type: Article

References (60)

1. Balosso S., Ravizza, Pierucci M., Calcagno E., Invernizzi R., Di Giovanni G., Esposito E., Vezzani A. Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience 2009, 161:293-300.
2. Baune B.T., Ponath G., Rothermund M., Riess O., Funke H., Berger K. Association between genetic variants of IL-beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology 2008, 33:68-76.
3. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., et al. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285.
4. Besser M.J., Ganor Y., Levite M. Dopamine by itself activates either D2, D3 or D1/D5 dopoaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNF alpha or both. Journal of Neuroimmunology 2005, 169:161-171.
5. Beste C., Willemssen R., Saft C., Falkenstein M. Response inhibition subprocesses and dopaminergic pathways: Basal ganglia disease effects. Neuropsychologia 2010, 48:366-373.
6. Beste C., Baune B.T., Domschke K., Falkenstein M., Konrad C. Paradoxical association of the brain-derived neurotrophic factor val66met with response inhibition. Neuroscience 2010, 166:178-184.
7. Beste C., Kolev V., Yordanova J., Domschke K., Falkenstein M., Baune B.T., et al. The role of the BDNF Val66Met polymorphism for the synchronization of error-specific neural networks. Journal of Neuroscience 2010, 30:10727-10733.
8. Beste C., Baune B.T., Domschke K., Falkenstein M., Konrad C. Dissociable influences of NR2B-receptor related neural transmission on functions of distinct associative basal ganglia circuits. NeuroImage 2010, 52:309-315.
9. Beste C., Kolev V., Yordanova J., Domschke K., Falkenstein M., Baune B.T., et al. The role of the BDNF Val66Met polymorphism for the synchronization of error-specific neural networks. Journal of Neuroscience 2010, 30:10727-10733.
10. Beste C., Heil M., Domschke K., Baune B.T., Konrad C. Associations between the TNF-α gene (-308G(A) and event-related potential indices of attention and mental rotation. Neuoscience 2010, 170:742-748.
11. Beste C., Willemssen R., Saft C., Falkenstein M. Error processing in normal aging and in basal ganglia disorders. Neuroscience 2009, 159:143-149.
12. Beste C., Dziobek I., Hielscher H., Willemssen R., Falkenstein M. Effects of stimulus-response compatibility on inhibitory processes in Parkinson's disease. The European Journal of Neuroscience 2009, 29:855-860.
13. Beste C., Saft C., Andrich J., Gold R., Falkenstein M. Response inhibition in Huntington's disease - A study using ERPs and sLORETA. Neuropsychologia 2008, 46:1290-1297.
14. Beste C., Saft C., Konrad C., Andrich J., Habbel A., Schepers I., et al. Levels of error processing in Huntington's disease: A combined study using event-related potentials and voxel-based morphometry. Human Brain Mapping 2008, 29:121-130.
15. Beste C., Saft C., Andrich J., Gold R., Falkenstein M. Stimulus-response compatibility in Huntington's disease: A cognitive-neurophysiological analysis. Journal of Neurophysiology 2008, 99:1213-1223.
16. Beste C., Saft C., Andrich J., Müller T., Gold R., Falkenstein M. Time processing in Huntington's disease: A group-control study. PloS One 2007, e:1263.
17. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neuroscience Letters 1994, 172:151-154.
18. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends in Cognitive Sciences 2000, 4:215-222.
19. Chudasama Y., Robbins T.W. Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans. Biological Psychology 2006, 73:19-38.
20. Debener S., Ullsperger M., Siegel M., Fiehler K., von Cramon D.Y., Engel A.K. Trial-by-trial coupling of concurrent electroencephalogram and functional magnetic resonance imaging identifies the dynamics of performance monitoring. Journal of Neuroscience 2005, 25:11730-11737.
21. DeLong M.R., Wichmann T. Circuits and circuit disorders of the basal ganglia. Archives of Neurology 2007, 64:20-24.
22. Falkenstein M., Hielscher H., Dziobek I., Schwarzenau P., Hoormann J., Sunderman B., et al. Action monitoring, error detection, and the basal ganglia: An ERP study. Neuroreport 2001, 12:157-161.
23. Falkenstein M., Hoormann J., Hohnsbein J. ERP components in Go/Nogo tasks and their relation to inhibition. Acta Psychologica 1999, 101:267-291.
24. Falkenstein M., Hohnsbein J., Hoormann J., Blanke L. Effects of crossmodal divided attention on the ERP components. II. Error processing in choice reaction tasks. Electroencephalography and Clinical Neurophysiology 1991, 78:447-455.
25. Floresco S.B., West A.R., Ash B., Moore H., Grace A.A. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nature Neuroscience 2003, 6:968-973.
26. Gale J.T., Amirnovin R., Williams Z.M., Flaherty A.W., Eskandar E.N. From symphony to cacophony: Pathophysiology of the human basal ganglia in Parkinson's disease. Neuroscience and Biobehavioural Reviews 2008, 32:378-387.
27. Gehring W.J., Goss B., Coles M.G.H., Meyer D.E., Donchin E. A neural system for error detection and compensation. Psychological Science 1993, 4:385-390.
28. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis of the etiology of schizophrenia. Neuroscience 1991, 41:1-24.
29. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artefact. Electroencephalography and Clinical Neurophysiology 1983, 55:468-484.
30. Hajeer A.H., Hutchison I.V. Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Humam Immunology 2001, 62:1191-1199.
31. Holroyd C.B., Coles M.G.H. The neural basis of human error processing: Reinforcement learning, dopamine, and the error-related negativity. Psychological Review 2002, 109:679-709.
32. Kopp B., Rist F., Mattler U. N200 in the flanker task as a neurobehavioral tool for investigating executive control. Psychophysiology 1996, 33:282-294.
33. Kravitz A.V., Freeze B.S., Parker P.R.L., Kay K., Thwin M.T., Deisseroth K., et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 2010, 466:622-626.
34. McCoy M.K., Tansey M.G. TNF signalling in the CNS: Implications for normal brain function and neurodegenerative disease. Journal of Neuroinflammation 2008, 5:45.
35. McNally R.J. Anxiety sensitivity and panic disorder. Biological Psychiatry 2002, 52:938-946.
36. Nakajima A., Yamada K., Nagai T., Uchiyama T., Miyamoto Y., Mamiya T., et al. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. Journal of Neuroscience 2004, 24:2212-2225.
37. Nieuwenhuis S., Yeung N., van den Wildenberg W., Ridderinkhof K.R. Electrophysiological correlates of anterior cingulate function in a go/no-go task: Effects of response conflict and trial type frequency. Cognitive Affective and Behavioural Neuroscience 2003, 3:17-26.
38. Niwa M., Yamada Y., Nakajima A., Seishima M., Noda Y., Nabeshima T. Tumor necrosis factor-alpha and its inducer inhibit morphine-induced rewarding effects and sensitization. Biological Psychiatry 2007, 62:658-668.
39. Oeth, P., Beaulieu, M., Park, C., Kosman, D., del Mistro, G., & van den Boom, et al. (2007). iPLEX™ Assay: Increased Plexing Efficiency and Flexibility for MassARRAY System Through Single Base Primer Extension with Mass-Modified Terminators. http://www.agrf.org.au/docstore/snp/iPlex.pdf.
40. Pickering M., Cumiskey D., O'Connor J.J. Actions of TNF-α on glutamatergic synaptic transmission in the central nervous system. Experimental Physiology 2005, 90:663-670.
41. Rainero I., Grimaldi L.M.E., Salani G., Valfre V., Rivoiro C., Savi L. Association between the tumor necrosis factor-α -308G/A gene polymorphism and migraine. Neurology 2004, 62:141-143.
42. Rabbitt P.M. Error correction time without external error signals. Nature 1966, 212-438.
43. Ridderinkhof K.R., Ullsperger M., Crone E.A., Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science 2004, 306:443-447.
44. Roche G.A., Garavan H., Foxe J.J., O'Mara S.M. Individual differences discriminate event-related potentials but not performance during response inhibition. Experimental Brain Research 2005, 160:30-70.
45. Ruchsow M., Herrnberger B., Beschoner P., Grön G., Spitzer M., Kiefer M. Error processing in major depressive disorder: Evidence from event-related potentials. Journal of Psychiatry Research 2006, 40:37-46.
46. Saft C., Schüttke A., Beste C., Andrich J., Heindel W., Pfleiderer B. fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease. Neuropsychologia 2008, 46:1279-1289.
47. Sawada M., Imamura K., Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. Journal of Neural Transmission 2006, 70:373-381.
48. Schmajuk M., Liotti M., Busse L., Woldorff M.G. Electrophysiological activity underlying inhibitory control processes in normal adults. Neuropsychologia 2006, 44:384-395.
49. Schoenbaum G., Roesch M.R., et al. A new perspective on the role of the orbitofrontal cortex in adaptive behaviour. Nature Reviews Neuroscience 2009, 10:885-892.
50. Schultz W. Multiple dopamine functions at different time courses. Annual Review of Neuroscience 2007, 30:259-288.
51. Sehlmeyer C., Konrad C., Zwitserlood P., Arolt V., Falkenstein M., Beste C. ERP indices for response inhibition are related to anxiety-related personality traits. Neuropsychologia 2010, 48:2488-2495.
52. Sriram K., O'Callaghan J.P. Divergent roles for tumor necrosis factor-alpha in the brain. Journal of Neuroimmune Pharmacology 2007, 2:140-153.
53. Sriram K., Miller D.B., O'Callaghan J.P. Minocycline attenuates microglial activation but fails to mitigate striatal dopoaminergic neurotoxicity: Role of tumor necrosis factor-alpha. Journal of Neurochemistry 2006, 96:706-718.
54. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., O'Callaghan J.P. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2002, 16:1474-1476.
55. Tansey M.G., Frank-Cannon T.C., McCoy M.K., Lee J.K., Martinez T.N., McAlpine F.E., et al. Neuroinflammation in Parkinson's disease: Is there sufficient evidence for mechanism-based interventional therapy?. Frontiers in Biosciences 2008, 13:709-717.
56. Wei F., Guo W., Zou S., Ren K., Dubner R. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. Journal of Neuroscience 2008, 28:10482-10495.
57. Wild-Wall N., Willemssen R., Falkenstein M., Beste C. Time estimation in healthy aging and neurodegenerative basal ganglia disorders. Neuroscience Letters 2008, 442:34-38.
58. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:3195-3199.
59. Yamada K. Endogenous modulators for drug dependence. Biological and Pharmaceutical Bulletin 2008, 31:1635-1638.
60. Yeung N., Botvinick M.M., Cohen J.D. The neural basis of error detection: Conflict monitoring and the error-related negativity. Psychological Reviews 2004, 111:931-959.